PlasmaGen Biosciences secures ₹150 crore to expand into global markets
Biopharmaceutical company PlasmaGen Biosciences raised ₹150 crore in a new round of equity financing, valuing the company at over ₹1,500 crore. ViNS Bioproducts, a specialty biopharma company, picked up a…







